Dr Reddys Laboratories Share Price Today - Live Blog for August 29, 2025

The stock of Dr Reddys Laboratories Ltd is facing a -0.20% decline and is currently trading at ₹1,257.85 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.20% slump and is currently trading at ₹1,257.85. While the stock maintains a PE ratio of 18.5200, the industry PE is 34.6564, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.03%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,260.90 per share.

The share price of Dr Reddys Laboratories Ltd experienced a -0.03% slump and is currently trading at ₹1,260.25. While the stock maintains a PE ratio of 18.5200, the industry PE is 34.6564, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price stayed unchanged, currently trading at ₹1,260.00. The stock has a PE ratio of 18.5200, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a -0.10% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,259.85. The stock has a PE ratio of 18.5200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd remained constant, with no changes. It is currently at ₹1,260.15. Investors may use this period of stability to conduct a thorough analysis of the stock's performance.

Dr Reddys Laboratories Ltd observed a -0.08% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,261.00. The stock has a PE ratio of 18.5200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.11% uptick, and they are currently valued at ₹1,262.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

There was no alteration in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,260.00. This lack of change could lead investors to revisit their investment strategies and consider the stock's valuation.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.08% drop, and it's now trading at ₹1,259.75 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd witnessed a -0.05% decrease in its share price, and it is currently trading at ₹1,260.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.5200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.21%. At this moment, it's actively trading at ₹1,261.15, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.21%, reaching the current market price of ₹1,261.15. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd stock price decreased by -0.01%, with the current market value at ₹1,258.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd is facing a -0.01% decline and is currently trading at ₹1,258.50 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd experienced a -0.10% dip in its share price and is currently trading at ₹1,258.75. The stock has a PE ratio of 18.5200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a -0.10% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,258.75. The stock has a PE ratio of 18.5200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,260.00. The stock has a PE ratio of 18.5200, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.04% upswing, and it's currently trading at ₹1,260.00 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.64% recently. As of now, this stock is actively trading at a current market price of ₹1,259.05 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd experienced a -0.21% dip in its share price and is currently trading at ₹1,251.95. The stock has a PE ratio of 18.5200, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.34% upswing, and it's currently trading at ₹1,253.00 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's stock price surged by 0.24%, reaching the current market value of ₹1,248.85 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.13% upswing and is currently trading at ₹1,245.30, indicating strong market sentiment.

Dr Reddys Laboratories Ltd stock price decreased by -0.67%, with the current market value at ₹1,243.80 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd stock price decreased by -0.82%, with the current market value at ₹1,251.30 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Demonstrating a commendable 0.07% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,261.90. In terms of valuation, the stock maintains a PE ratio of 18.5200, while the industry PE ratio stands at 34.6564.